VIR earnings date and last-quarter result: last quarter beat, P/E -2.99. Updated 2026-07-23.
Vir Biotechnology (VIR) Research Hub
Vir Biotechnology (VIR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 11.04 USD (+4.45%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.99, market cap 1.57B. This hub links to the full technical, earnings and options research available for VIR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 11.04 USD (+4.45%) |
| 52-week range | 8.52 USD – 12 USD |
| Trend regime | Range |
| 14-day RSI | 43.9 (Bearish) |
| Trailing P/E | -2.99 |
| Market cap | 1.57B |
| Dividend yield | 0.00% |
Available research for VIR
Covered Call on VIR: how it works, illustrative setup around the real 11.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VIR: how it works, illustrative setup around the real 11.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VIR: how it works, illustrative setup around the real 11.04 USD price, max profit/loss, breakeven and when to use it. Educational.
VIR technical analysis: range, last 11.04 USD, RSI 43.9, 52w range 8.52 USD–12 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is VIR in?
Vir Biotechnology (VIR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VIR in an uptrend or downtrend?
As of 2026-10-26, VIR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VIR's trailing P/E ratio?
VIR's trailing P/E is -2.99, with a market cap of 1.57B. See the earnings research page for full valuation detail.